Connection

Andreas Peter to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Andreas Peter has written about Diabetes Mellitus, Type 2.
Andreas Peter
Connection Strength
0.437
Diabetes Mellitus, Type 2
  1. Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance. Mol Metab. 2021 11; 53:101262.
    View in: PubMed
    Score: 0.202
  2. Cellular markers of eryptosis are altered in type 2 diabetes. Clin Chem Lab Med. 2018 06 27; 56(7):e177-e180.
    View in: PubMed
    Score: 0.041
  3. Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in Humans. Sci Rep. 2018 05 17; 8(1):7745.
    View in: PubMed
    Score: 0.041
  4. Androgen receptor overexpression in prostate cancer in type 2 diabetes. Mol Metab. 2018 02; 8:158-166.
    View in: PubMed
    Score: 0.040
  5. Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. Diabetologia. 2017 12; 60(12):2341-2351.
    View in: PubMed
    Score: 0.039
  6. Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis. Nephrol Dial Transplant. 2017 04 01; 32(4):670-676.
    View in: PubMed
    Score: 0.038
  7. Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus. Sci Rep. 2017 01 16; 7:40627.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.